Report Overview
Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.
The global Orexin Receptor Antagonists market size was estimated at USD 4521 million in 2023 and is projected to reach USD 7768.82 million by 2032, exhibiting a CAGR of 6.20% during the forecast period.
North America Orexin Receptor Antagonists market size was estimated at USD 1306.58 million in 2023, at a CAGR of 5.31% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Orexin Receptor Antagonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Orexin Receptor Antagonists Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Orexin Receptor Antagonists market in any manner.
Global Orexin Receptor Antagonists Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eisai Co.
Ltd
Sun Pharmaceutical Industries Ltd
Novartis AG
Endo Pharmaceuticals plc
Mylan NV
Cereve Inc.
Teva Pharmaceutical Industries Ltd
Amneal Pharmaceuticals Inc
Merck & Co.
Sanofi
Currax Pharmaceuticals LLC
Pfizer Inc.
Market Segmentation (by Type)
Oral
Parenteral
Market Segmentation (by Application)
Insomnia
Anxious
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Orexin Receptor Antagonists Market
Overview of the regional outlook of the Orexin Receptor Antagonists Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical
scope of the report, market division standards, and market research methods.
Chapter 2 is an executive
summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orexin Receptor Antagonists Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Orexin Receptor Antagonists, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Orexin Receptor Antagonists
1.2 Key Market Segments
1.2.1 Orexin Receptor Antagonists Segment by Type
1.2.2 Orexin Receptor Antagonists Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Orexin Receptor Antagonists Market Overview
2.1 Global Market Overview
2.1.1 Global Orexin Receptor Antagonists Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Orexin Receptor Antagonists Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Orexin Receptor Antagonists Market Competitive Landscape
3.1 Global Orexin Receptor Antagonists Sales by Manufacturers (2019-2024)
3.2 Global Orexin Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
3.3 Orexin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orexin Receptor Antagonists Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Orexin Receptor Antagonists Sales Sites, Area Served, Product Type
3.6 Orexin Receptor Antagonists Market Competitive Situation and Trends
3.6.1 Orexin Receptor Antagonists Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orexin Receptor Antagonists Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Orexin Receptor Antagonists Industry Chain Analysis
4.1 Orexin Receptor Antagonists Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Orexin Receptor Antagonists Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Orexin Receptor Antagonists Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orexin Receptor Antagonists Sales Market Share by Type (2019-2024)
6.3 Global Orexin Receptor Antagonists Market Size Market Share by Type (2019-2024)
6.4 Global Orexin Receptor Antagonists Price by Type (2019-2024)
7 Orexin Receptor Antagonists Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orexin Receptor Antagonists Market Sales by Application (2019-2024)
7.3 Global Orexin Receptor Antagonists Market Size (M USD) by Application (2019-2024)
7.4 Global Orexin Receptor Antagonists Sales Growth Rate by Application (2019-2024)
8 Orexin Receptor Antagonists Market Consumption by Region
8.1 Global Orexin Receptor Antagonists Sales by Region
8.1.1 Global Orexin Receptor Antagonists Sales by Region
8.1.2 Global Orexin Receptor Antagonists Sales Market Share by Region
8.2 North America
8.2.1 North America Orexin Receptor Antagonists Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orexin Receptor Antagonists Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orexin Receptor Antagonists Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orexin Receptor Antagonists Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orexin Receptor Antagonists Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Orexin Receptor Antagonists Market Production by Region
9.1 Global Production of Orexin Receptor Antagonists by Region (2019-2024)
9.2 Global Orexin Receptor Antagonists Revenue Market Share by Region (2019-2024)
9.3 Global Orexin Receptor Antagonists Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Orexin Receptor Antagonists Production
9.4.1 North America Orexin Receptor Antagonists Production Growth Rate (2019-2024)
9.4.2 North America Orexin Receptor Antagonists Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Orexin Receptor Antagonists Production
9.5.1 Europe Orexin Receptor Antagonists Production Growth Rate (2019-2024)
9.5.2 Europe Orexin Receptor Antagonists Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Orexin Receptor Antagonists Production (2019-2024)
9.6.1 Japan Orexin Receptor Antagonists Production Growth Rate (2019-2024)
9.6.2 Japan Orexin Receptor Antagonists Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Orexin Receptor Antagonists Production (2019-2024)
9.7.1 China Orexin Receptor Antagonists Production Growth Rate (2019-2024)
9.7.2 China Orexin Receptor Antagonists Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Eisai Co.
10.1.1 Eisai Co. Orexin Receptor Antagonists Basic Information
10.1.2 Eisai Co. Orexin Receptor Antagonists Product Overview
10.1.3 Eisai Co. Orexin Receptor Antagonists Product Market Performance
10.1.4 Eisai Co. Business Overview
10.1.5 Eisai Co. Orexin Receptor Antagonists SWOT Analysis
10.1.6 Eisai Co. Recent Developments
10.2 Ltd
10.2.1 Ltd Orexin Receptor Antagonists Basic Information
10.2.2 Ltd Orexin Receptor Antagonists Product Overview
10.2.3 Ltd Orexin Receptor Antagonists Product Market Performance
10.2.4 Ltd Business Overview
10.2.5 Ltd Orexin Receptor Antagonists SWOT Analysis
10.2.6 Ltd Recent Developments
10.3 Sun Pharmaceutical Industries Ltd
10.3.1 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Basic Information
10.3.2 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Overview
10.3.3 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Market Performance
10.3.4 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists SWOT Analysis
10.3.5 Sun Pharmaceutical Industries Ltd Business Overview
10.3.6 Sun Pharmaceutical Industries Ltd Recent Developments
10.4 Novartis AG
10.4.1 Novartis AG Orexin Receptor Antagonists Basic Information
10.4.2 Novartis AG Orexin Receptor Antagonists Product Overview
10.4.3 Novartis AG Orexin Receptor Antagonists Product Market Performance
10.4.4 Novartis AG Business Overview
10.4.5 Novartis AG Recent Developments
10.5 Endo Pharmaceuticals plc
10.5.1 Endo Pharmaceuticals plc Orexin Receptor Antagonists Basic Information
10.5.2 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Overview
10.5.3 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Market Performance
10.5.4 Endo Pharmaceuticals plc Business Overview
10.5.5 Endo Pharmaceuticals plc Recent Developments
10.6 Mylan NV
10.6.1 Mylan NV Orexin Receptor Antagonists Basic Information
10.6.2 Mylan NV Orexin Receptor Antagonists Product Overview
10.6.3 Mylan NV Orexin Receptor Antagonists Product Market Performance
10.6.4 Mylan NV Business Overview
10.6.5 Mylan NV Recent Developments
10.7 Cereve Inc.
10.7.1 Cereve Inc. Orexin Receptor Antagonists Basic Information
10.7.2 Cereve Inc. Orexin Receptor Antagonists Product Overview
10.7.3 Cereve Inc. Orexin Receptor Antagonists Product Market Performance
10.7.4 Cereve Inc. Business Overview
10.7.5 Cereve Inc. Recent Developments
10.8 Teva Pharmaceutical Industries Ltd
10.8.1 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Basic Information
10.8.2 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Overview
10.8.3 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Market Performance
10.8.4 Teva Pharmaceutical Industries Ltd Business Overview
10.8.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.9 Amneal Pharmaceuticals Inc
10.9.1 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Basic Information
10.9.2 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Overview
10.9.3 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Market Performance
10.9.4 Amneal Pharmaceuticals Inc Business Overview
10.9.5 Amneal Pharmaceuticals Inc Recent Developments
10.10 Merck and Co.
10.10.1 Merck and Co. Orexin Receptor Antagonists Basic Information
10.10.2 Merck and Co. Orexin Receptor Antagonists Product Overview
10.10.3 Merck and Co. Orexin Receptor Antagonists Product Market Performance
10.10.4 Merck and Co. Business Overview
10.10.5 Merck and Co. Recent Developments
10.11 Sanofi
10.11.1 Sanofi Orexin Receptor Antagonists Basic Information
10.11.2 Sanofi Orexin Receptor Antagonists Product Overview
10.11.3 Sanofi Orexin Receptor Antagonists Product Market Performance
10.11.4 Sanofi Business Overview
10.11.5 Sanofi Recent Developments
10.12 Currax Pharmaceuticals LLC
10.12.1 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Basic Information
10.12.2 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Overview
10.12.3 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Market Performance
10.12.4 Currax Pharmaceuticals LLC Business Overview
10.12.5 Currax Pharmaceuticals LLC Recent Developments
10.13 Pfizer Inc.
10.13.1 Pfizer Inc. Orexin Receptor Antagonists Basic Information
10.13.2 Pfizer Inc. Orexin Receptor Antagonists Product Overview
10.13.3 Pfizer Inc. Orexin Receptor Antagonists Product Market Performance
10.13.4 Pfizer Inc. Business Overview
10.13.5 Pfizer Inc. Recent Developments
11 Orexin Receptor Antagonists Market Forecast by Region
11.1 Global Orexin Receptor Antagonists Market Size Forecast
11.2 Global Orexin Receptor Antagonists Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Orexin Receptor Antagonists Market Size Forecast by Country
11.2.3 Asia Pacific Orexin Receptor Antagonists Market Size Forecast by Region
11.2.4 South America Orexin Receptor Antagonists Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Orexin Receptor Antagonists by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Orexin Receptor Antagonists Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Orexin Receptor Antagonists by Type (2025-2032)
12.1.2 Global Orexin Receptor Antagonists Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Orexin Receptor Antagonists by Type (2025-2032)
12.2 Global Orexin Receptor Antagonists Market Forecast by Application (2025-2032)
12.2.1 Global Orexin Receptor Antagonists Sales (K MT) Forecast by Application
12.2.2 Global Orexin Receptor Antagonists Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Orexin Receptor Antagonists Market Size Comparison by Region (M USD)
Table 5. Global Orexin Receptor Antagonists Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Orexin Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Orexin Receptor Antagonists Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Orexin Receptor Antagonists Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orexin Receptor Antagonists as of 2022)
Table 10. Global Market Orexin Receptor Antagonists Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Orexin Receptor Antagonists Sales Sites and Area Served
Table 12. Manufacturers Orexin Receptor Antagonists Product Type
Table 13. Global Orexin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Orexin Receptor Antagonists
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Orexin Receptor Antagonists Market Challenges
Table 22. Global Orexin Receptor Antagonists Sales by Type (K MT)
Table 23. Global Orexin Receptor Antagonists Market Size by Type (M USD)
Table 24. Global Orexin Receptor Antagonists Sales (K MT) by Type (2019-2024)
Table 25. Global Orexin Receptor Antagonists Sales Market Share by Type (2019-2024)
Table 26. Global Orexin Receptor Antagonists Market Size (M USD) by Type (2019-2024)
Table 27. Global Orexin Receptor Antagonists Market Size Share by Type (2019-2024)
Table 28. Global Orexin Receptor Antagonists Price (USD/MT) by Type (2019-2024)
Table 29. Global Orexin Receptor Antagonists Sales (K MT) by Application
Table 30. Global Orexin Receptor Antagonists Market Size by Application
Table 31. Global Orexin Receptor Antagonists Sales by Application (2019-2024) & (K MT)
Table 32. Global Orexin Receptor Antagonists Sales Market Share by Application (2019-2024)
Table 33. Global Orexin Receptor Antagonists Sales by Application (2019-2024) & (M USD)
Table 34. Global Orexin Receptor Antagonists Market Share by Application (2019-2024)
Table 35. Global Orexin Receptor Antagonists Sales Growth Rate by Application (2019-2024)
Table 36. Global Orexin Receptor Antagonists Sales by Region (2019-2024) & (K MT)
Table 37. Global Orexin Receptor Antagonists Sales Market Share by Region (2019-2024)
Table 38. North America Orexin Receptor Antagonists Sales by Country (2019-2024) & (K MT)
Table 39. Europe Orexin Receptor Antagonists Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Orexin Receptor Antagonists Sales by Region (2019-2024) & (K MT)
Table 41. South America Orexin Receptor Antagonists Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Orexin Receptor Antagonists Sales by Region (2019-2024) & (K MT)
Table 43. Global Orexin Receptor Antagonists Production (K MT) by Region (2019-2024)
Table 44. Global Orexin Receptor Antagonists Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Orexin Receptor Antagonists Revenue Market Share by Region (2019-2024)
Table 46. Global Orexin Receptor Antagonists Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Orexin Receptor Antagonists Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Orexin Receptor Antagonists Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Orexin Receptor Antagonists Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Orexin Receptor Antagonists Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Eisai Co. Orexin Receptor Antagonists Basic Information
Table 52. Eisai Co. Orexin Receptor Antagonists Product Overview
Table 53. Eisai Co. Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Eisai Co. Business Overview
Table 55. Eisai Co. Orexin Receptor Antagonists SWOT Analysis
Table 56. Eisai Co. Recent Developments
Table 57. Ltd Orexin Receptor Antagonists Basic Information
Table 58. Ltd Orexin Receptor Antagonists Product Overview
Table 59. Ltd Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Ltd Business Overview
Table 61. Ltd Orexin Receptor Antagonists SWOT Analysis
Table 62. Ltd Recent Developments
Table 63. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Basic Information
Table 64. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Overview
Table 65. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists SWOT Analysis
Table 67. Sun Pharmaceutical Industries Ltd Business Overview
Table 68. Sun Pharmaceutical Industries Ltd Recent Developments
Table 69. Novartis AG Orexin Receptor Antagonists Basic Information
Table 70. Novartis AG Orexin Receptor Antagonists Product Overview
Table 71. Novartis AG Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Novartis AG Business Overview
Table 73. Novartis AG Recent Developments
Table 74. Endo Pharmaceuticals plc Orexin Receptor Antagonists Basic Information
Table 75. Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Overview
Table 76. Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Endo Pharmaceuticals plc Business Overview
Table 78. Endo Pharmaceuticals plc Recent Developments
Table 79. Mylan NV Orexin Receptor Antagonists Basic Information
Table 80. Mylan NV Orexin Receptor Antagonists Product Overview
Table 81. Mylan NV Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Mylan NV Business Overview
Table 83. Mylan NV Recent Developments
Table 84. Cereve Inc. Orexin Receptor Antagonists Basic Information
Table 85. Cereve Inc. Orexin Receptor Antagonists Product Overview
Table 86. Cereve Inc. Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Cereve Inc. Business Overview
Table 88. Cereve Inc. Recent Developments
Table 89. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Basic Information
Table 90. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Overview
Table 91. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Teva Pharmaceutical Industries Ltd Business Overview
Table 93. Teva Pharmaceutical Industries Ltd Recent Developments
Table 94. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Basic Information
Table 95. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Overview
Table 96. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Amneal Pharmaceuticals Inc Business Overview
Table 98. Amneal Pharmaceuticals Inc Recent Developments
Table 99. Merck and Co. Orexin Receptor Antagonists Basic Information
Table 100. Merck and Co. Orexin Receptor Antagonists Product Overview
Table 101. Merck and Co. Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Merck and Co. Business Overview
Table 103. Merck and Co. Recent Developments
Table 104. Sanofi Orexin Receptor Antagonists Basic Information
Table 105. Sanofi Orexin Receptor Antagonists Product Overview
Table 106. Sanofi Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Sanofi Business Overview
Table 108. Sanofi Recent Developments
Table 109. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Basic Information
Table 110. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Overview
Table 111. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Currax Pharmaceuticals LLC Business Overview
Table 113. Currax Pharmaceuticals LLC Recent Developments
Table 114. Pfizer Inc. Orexin Receptor Antagonists Basic Information
Table 115. Pfizer Inc. Orexin Receptor Antagonists Product Overview
Table 116. Pfizer Inc. Orexin Receptor Antagonists Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Pfizer Inc. Business Overview
Table 118. Pfizer Inc. Recent Developments
Table 119. Global Orexin Receptor Antagonists Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Orexin Receptor Antagonists Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Orexin Receptor Antagonists Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Orexin Receptor Antagonists Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Orexin Receptor Antagonists Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Orexin Receptor Antagonists Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Orexin Receptor Antagonists Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Orexin Receptor Antagonists Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Orexin Receptor Antagonists Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Orexin Receptor Antagonists Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Orexin Receptor Antagonists Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Orexin Receptor Antagonists Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Orexin Receptor Antagonists Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Orexin Receptor Antagonists Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Orexin Receptor Antagonists Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Orexin Receptor Antagonists Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Orexin Receptor Antagonists Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Orexin Receptor Antagonists
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Orexin Receptor Antagonists Market Size (M USD), 2019-2032
Figure 5. Global Orexin Receptor Antagonists Market Size (M USD) (2019-2032)
Figure 6. Global Orexin Receptor Antagonists Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Orexin Receptor Antagonists Market Size by Country (M USD)
Figure 11. Orexin Receptor Antagonists Sales Share by Manufacturers in 2023
Figure 12. Global Orexin Receptor Antagonists Revenue Share by Manufacturers in 2023
Figure 13. Orexin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Orexin Receptor Antagonists Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Orexin Receptor Antagonists Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Orexin Receptor Antagonists Market Share by Type
Figure 18. Sales Market Share of Orexin Receptor Antagonists by Type (2019-2024)
Figure 19. Sales Market Share of Orexin Receptor Antagonists by Type in 2023
Figure 20. Market Size Share of Orexin Receptor Antagonists by Type (2019-2024)
Figure 21. Market Size Market Share of Orexin Receptor Antagonists by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Orexin Receptor Antagonists Market Share by Application
Figure 24. Global Orexin Receptor Antagonists Sales Market Share by Application (2019-2024)
Figure 25. Global Orexin Receptor Antagonists Sales Market Share by Application in 2023
Figure 26. Global Orexin Receptor Antagonists Market Share by Application (2019-2024)
Figure 27. Global Orexin Receptor Antagonists Market Share by Application in 2023
Figure 28. Global Orexin Receptor Antagonists Sales Growth Rate by Application (2019-2024)
Figure 29. Global Orexin Receptor Antagonists Sales Market Share by Region (2019-2024)
Figure 30. North America Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Orexin Receptor Antagonists Sales Market Share by Country in 2023
Figure 32. U.S. Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Orexin Receptor Antagonists Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Orexin Receptor Antagonists Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Orexin Receptor Antagonists Sales Market Share by Country in 2023
Figure 37. Germany Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Orexin Receptor Antagonists Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Orexin Receptor Antagonists Sales Market Share by Region in 2023
Figure 44. China Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Orexin Receptor Antagonists Sales and Growth Rate (K MT)
Figure 50. South America Orexin Receptor Antagonists Sales Market Share by Country in 2023
Figure 51. Brazil Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Orexin Receptor Antagonists Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Orexin Receptor Antagonists Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Orexin Receptor Antagonists Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Orexin Receptor Antagonists Production Market Share by Region (2019-2024)
Figure 62. North America Orexin Receptor Antagonists Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Orexin Receptor Antagonists Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Orexin Receptor Antagonists Production (K MT) Growth Rate (2019-2024)
Figure 65. China Orexin Receptor Antagonists Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Orexin Receptor Antagonists Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Orexin Receptor Antagonists Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Orexin Receptor Antagonists Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Orexin Receptor Antagonists Market Share Forecast by Type (2025-2032)
Figure 70. Global Orexin Receptor Antagonists Sales Forecast by Application (2025-2032)
Figure 71. Global Orexin Receptor Antagonists Market Share Forecast by Application (2025-2032)
